These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1325581)

  • 81. A fifteen-year review of lymphomas in a Nigerian tertiary healthcare centre.
    Oluwasola AO; Olaniyi JA; Otegbayo JA; Ogun GO; Akingbola TS; Ukah CO; Akang EE; Aken'Ova YA
    J Health Popul Nutr; 2011 Aug; 29(4):310-6. PubMed ID: 21957669
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Hematologic characteristics in Black Africa].
    Rain JD
    Ann Biol Clin (Paris); 1988; 46(1):66-9. PubMed ID: 3291651
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The geographic pathology of children's lymphomas.
    JAMA; 1969 May; 208(8):1484. PubMed ID: 4305835
    [No Abstract]   [Full Text] [Related]  

  • 84. [Geographic hematology].
    Bernard J
    Nouv Rev Fr Hematol; 1975; 15(6):683-98. PubMed ID: 133338
    [No Abstract]   [Full Text] [Related]  

  • 85. Is rheumatoid arthritis in African descendants from North and South America the same?
    Alarcón GS
    Semin Arthritis Rheum; 2001 Dec; 31(3):143-5. PubMed ID: 11740795
    [No Abstract]   [Full Text] [Related]  

  • 86. Denis Burkitt and the African lymphoma.
    Magrath I
    Ecancermedicalscience; 2009; 3():159. PubMed ID: 22276020
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An Indian Perspective on HIV-associated Lymphomas.
    Barta SK
    N Am J Med Sci; 2013 Jul; 5(7):438-9. PubMed ID: 24020056
    [No Abstract]   [Full Text] [Related]  

  • 88. What keeps the power on in lymphomas?
    Hammerschmidt W
    Blood; 2011 Feb; 117(6):1777-8. PubMed ID: 21310934
    [No Abstract]   [Full Text] [Related]  

  • 89. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in breast cancer.
    Jørgensen JT; Nielsen KV; Ejlertsen B
    Oncologist; 2007 Apr; 12(4):397-405. PubMed ID: 17470682
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
    Singh DR; Nelson SE; Pawelski AS; Cantres-Velez JA; Kansra AS; Pauly NP; Bristol JA; Hayes M; Ohashi M; Casco A; Lee D; Fogarty SA; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2022 Oct; 18(10):e1010868. PubMed ID: 36190982
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
    Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
    PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.
    Rochford R
    Ann Lymphoma; 2021 Sep; 5():. PubMed ID: 34888589
    [TBL] [Abstract][Full Text] [Related]  

  • 94. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
    Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
    Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.
    Coleman CB; Wohlford EM; Smith NA; King CA; Ritchie JA; Baresel PC; Kimura H; Rochford R
    J Virol; 2015 Feb; 89(4):2301-12. PubMed ID: 25505080
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease.
    Capello D; Gaidano G
    Mediterr J Hematol Infect Dis; 2009 Dec; 1(2):e2009018. PubMed ID: 21416004
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
    Chang CM; Yu KJ; Mbulaiteye SM; Hildesheim A; Bhatia K
    Virus Res; 2009 Aug; 143(2):209-21. PubMed ID: 19596032
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.
    Queiroga EM; Gualco G; Weiss LM; Dittmer DP; Araujo I; Klumb CE; Harrington WJ; Bacchi CE
    Am J Clin Pathol; 2008 Dec; 130(6):946-56. PubMed ID: 19019773
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
    Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
    Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.